Publications

Search our bibliography using the filters on the right-hand side.

Displaying 201 through 250 of 307 publications.

Sussman G, Lynde C, Zanganeh S, Lacuesta G, Chiva-Razavi S, Chambenoit O, Khalil S, Hollis KA, McBride DW, Westlund RE, Sweeney CT, Tian H, Balp MM. ASSURE-CSU preliminary Canadian results: an analysis of the diagnosis and treatment of patients with antihistamine-refractory CSU. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada. [abstract] Clin Transl Allergy. 2015 Aug 17; 5(29):1-7. doi: 10.1186/s13601-015-0072-9

Weller K, Maurer M, Grattan C, Nakonechna A, Abuzakouk M, Bérard F, Sussman G, Giménez-Arnau AM, Ortiz De Frutos J, Knulst A, Canonica GW, Hollis K, McBride D, Balp MM. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin Transl Allergy. 2015 Aug 17;17(5):29.

White MV, Goss D, Silvia S, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 FAAIS Annual Meeting; July 17, 2015. Orlando, FL. Previously presented at the 2015 AAAAI Annual Meeting.

Silvia S, Goss D, Wooddell M, Hogue S, White MV. Epinephrine administration for cases of anaphylaxis in a US school setting: results from the EpiPen4Schools® survey. Poster presented at the 2015 FAAIS Annual Meeting; July 17, 2015. Orlando, FL. Previously presented at the 2015 AAAAI Annual Meeting.

Sussman G, Lynde C, Kanani A, Hebert J, Chiva-Razavi S, Chambenoit O, Khalil S, Hollis KA, McBride DW, Westlund RE, Tian H, Balp MM. ASSURE-CSU preliminary Canadian results: redefining our understanding of the clinical characteristics of patients with CSU/CIU refractory to H1- antihistamines. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Sussman G, Grattan C, Lynde C, Abuzakouk M, Nakonechna A, Chiva-Razavi S, Halliday A, Chambenoit O, Hollis KA, McBride DW, Radder CN, Tian H, Balp MM. ASSURE-CSU preliminary UK and Canadian results: a characterisation of angioedema in patients with refractory CIU/CSU from the UK and Canada. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Sussman G, Nakonechna A, Lynde C, Grattan C, Halliday A, Chiva-Razavi S, Hollis KA, Balp MM. Impact of chronic idiopathic/ spontaneous urticaria on health related quality of life: aSSURE-CSU study results from Canada and the UK. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Grattan C, Balp MM, Halliday A, Abouzakouk M, Hollis KA, McBride DW, Westlund RE, Wolin DL, Tian H, Alexopoulos ST, Nakonechna A. ASSURE-CSU preliminary UK results: assessing the impact of CSU on absence from work and work productivity. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 Eastern Allergy Conference; May 28, 2015. Palm Beach, FL.

Sussman G, Lee J, Chiva-Razavi S, Chambenoit O, Hollis K, McBride D, Westlund R, Tian H, Balp MM. ASSURE-CSU Canadian results: assessing the impact of chronic spontaneous/idiopathic urticaria on work productivity and indirect costs. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Sussman G, Waserman S, Keith P, Chiva-Razavi S, Chambenoit O, Hollis K, McBride D, Westlund R. ASSURE-CSU Canadian results: assessing health utility in chronic spontaneous/idiopathic urticaria using the EQ-5D. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Schwab PE, Hopson S, Kaila S, Dhamane A, Moretz C, Burslem K, Jain G, Renda A. Associations between comorbidities and hospitalizations among patients with chronic obstructive pulmonary disease (COPD). Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Schwab PE, Hopson S, Kaila S, Dhamane A, Moretz C, Burslem K, Jain G, Renda A. Association between nonadherence to chronic obstructive pulmonary disease (COPD) maintenance medications and medications for other chronic conditions. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Liu W, Schwab PE, Lane D. Analysis of oral anti-diabetes medication splitting patterns in Medicare Advantage Prescription Drug (MAPD) plans population. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Rosen J, Lane D, Schwab PE. Comparison of telephonic vs. face-to-face comprehensive medication reviews in COPD patients. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Raspa M, Sacco PN, Edwards AM, Bishop E, Bailey DB, Loefroth E. A cross-country comparison of caregiver burden in fragile X syndrome. Poster presented at the 48th Annual Gatlinburg Conference; April 2015. New Orleans, LA.

Sussman G, Lynde CW, Chiva-Razavi S, Chambenoit O, Hollis K, Westlund RE, Balp MM. Canadian sub-analysis of the ASSURE-CSU study: demographic characteristics and health related quality of life in patients with chronic idiopathic urticaria. Poster presented at the American Academy of Dermatology Annual Meeting; March 21, 2015. San Francisco, CA.

Sussman G, Maurer M, Weller K, Nakonechna A, Abouzakouk M, Hollis K, McBride D, Balp MM, Berard F, Gimenez-Arnau AM, Frutos JO, Canonica GW, Knulst AC, Grattan C. Assessment of economic and humanistic burden of refractory chronic spontaneous/idiopathic urticaria: study design of the first observational study, ASSURE-CSU. Poster presented at the American Academy of Dermatology Annual Meeting; March 20, 2015.

Wooddell M, Goss DS, Hollis KA, Millar K, Silvia S, Siegel P, Bennett ME, Wolf RA, Hogue SL, White MV. Epinephrine administration for cases of anaphylaxis in a US school setting: results from the EpiPen4Schools survey. Poster presented at the 2015 AAAAI Annual Meeting; February 20, 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015 Feb; 135(2):AB212.

Harris JB, Ward MA, Schwab P. Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits. 2015 Feb;8(1):22-8.

White MV, Goss D, Hollis K, Millar K, Silvia S, Siegel P, Bennett ME, Wolf RA, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 AAAAI Annual Meeting; February 15, 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015 Feb; 135(Suppl 2):AB212.

White MV, Goss DS, Hollis KA, Millar K, Silvia S, Siegel P, Bennett ME, Wolf RA, Wooddell M, Hogue SL. EpiPen4Schools survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 AAAAI Annual Meeting; February 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015; 135:AB212.

Davis KH, Su J, González JM, Trudeau JJ, Nelson L, Hauber B, Hollis K. Assessment of patient satisfaction and preference of inhaler attributes in patients using combivent respimat. Poster presented at the Academy of Managed Care Pharmacy 2014 Nexus Conference; October 2014. Boston, MA.

Nakonechna A, Balp MM, Halliday A, Alexopoulos ST, Abouzakouk M, Hollis KA, McBride DW, Westlund RE, Grattan C, Tian H. UK sub-analysis of the ASSURE-CSU study: demographic characteristics and health related quality of life in patients with chronic spontaneous urticaria. Poster presented at the 23rd Congress of the European Academy of Dermatology and Venereology; October 2014. Amsterdam, the Netherlands.

Schwab P, Louder A, Li Y, Mallick R, Bays H. Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. Drugs Aging. 2014 Sep;31(9):683-94. doi: 10.1007/s40266-014-0200-6

Maurer M, Weller K, Nakonechna A, Abouzakouk M, Hollis KA, McBride DW, Georgiou P, Balp MM, Grattan C. The first international study assessing the economic and humanistic burden of refractory chronic spontaneous/idiopathic urticaria: aSSURE-CSU. Poster presented at the European Academy of Allergy and Clinical Immunology Congress; August 2014. Copenhagen, Denmark. [abstract] Allergy. 2014 Sep; 69(Suppl 99):122.

Hollis K, Gilsenan A. Design and implementation of surveys to assess patient and health care provider understanding of risks and safe use conditions. In: Andrews EB, Moore M, editors. Mann's pharmacovigilance. 3rd ed. Hoboken: NJ. John Wiley & Sons; 2014.

Schwab PE, Saundankar V, Bouchard J, Moretz C, Baltz J. Delayed treatment modifications for patients with type 2 diabetes mellitus with very poor glycemic control. Poster presented at the 2014 ISPOR 19th Annual International Meeting; May 31, 2014. Montreal, Canada. [abstract] Value Health. 2014 May; 17(3).

Seiffert R, Schwab PE, Slabaugh L, Rasca P. Descriptive analysis of prevalence and cost of bleeds and joint complications in factor product users. Poster presented at the 2014 Academy of Managed Care Pharmacy's 26th Annual Meeting & Expo; April 1, 2014. Tampa, FL.

James T, Ward M, Schwab PE, Slabaugh L, Saverno K, Anderson C. Cost-effectiveness analysis of triple and dual therapies in patients with chronic hepatitis C genotype 1 infections. Poster presented at the 2014 Academy of Managed Care Pharmacy's 26th Annual Meeting & Expo; April 1, 2014. Tampa, FL.

Wheeler A, Raspa M, Bann C, Bishop E, Hessl D, Sacco P, Bailey DBJr. Anxiety, attention problems, hyperactivity, and the aberrant behavior checklist in fragile x syndrome. Am J Med Genet A. 2014 Jan;164A(1):141-55. doi: 10.1002/ajmg.a.36232

Yu S, Schwab PE, Bian B, Nero D, Radican L, Tunceli K, Qui Y. Treatment patterns of type 2 diabetes mellitus patients on metformin monotherapy with suboptimal glycemic control: a U.S. database study. Poster presented at the 2013 International Diabetes Federation World Diabetes Congress; December 2, 2013. Melbourne, Australia.

Bhattacharyya S, Sacco P, Shirore R, Sonathi V, Thomas SK. A de novo economic model to assess the cost and quality of life consequences of an intervention for levodopa induced dyskinesia amongst patients with Parkinson's disease. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A590-1.

Schwab PE, Zhou Y, Stemkowski S, Barbato L, Zacker C. Analysis of first dose observation data for MS treatment with fingolimod (DX14). Poster presented at the 2013 Consortium for Multiple Sclerosis Centers and Americas Committee for Treatment and Research in Multiple Sclerosis 5th Cooperative Meeting; May 29, 2013. Orlando, FL.

Xe Y, Bays H, Schwab PE, Louder A. Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia. Poster presented at the 2013 American Heart Association Quality of Care and Outcomes Research (AHA QCOR) Scientific Sessions; May 15, 2013. Baltimore, MD.

Xe Y, Bays H, Schwab PE, Louder A. Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 18, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A295. doi: 10.1016/j.jval.2013.03.1529

Harris J, Ward M, Schwab PE. Adherence to HCV RNA laboratory monitoring guidelines and futility rules in protease inhibitor based triple therapy for the treatment of chronic HCV genotype 1 infection. Poster presented at the 2013 Academy of Managed Care Pharmacy's 25th Annual Meeting & Expo; April 2, 2013. CA.

Lennert B, Farrelly E, Sacco P, Pira G, Frost M. Resource utilization in children with tuberous sclerosis complex and associated seizures: a retrospective chart review study. J Child Neurol. 2013 Apr;28(4):461-9.

Sacco P, Capkun-Niggli G, Zhang X, Jose R. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013 Mar;6(2):73-83.

DiCesare J, Garrison L, Oster G, Sacco P. Assessing the reimbursability of new products: a structured approach. Presented at the 2012 ISPOR EUR Workshop; November 2012. Berlin, Germany.

Cohen JT, Marino RJ, Sacco P, Terrin N. Association between the functional independence measure following spinal cord injury and long-term outcomes. Spinal Cord. 2012 Oct;50(10):728-33. doi: 10.1038/sc.2012.50

Zografos L. Considerations for implementing surveys evaluating effectiveness: sample recruitment, ethics, and privacy. Presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 5, 2012. Barcelona.

Lennert B, Bibeau W, Farrelly E, Sacco P, Schoor T. Assessment of treatment patterns and patient outcomes in levodopa-induced dyskinesias (ASTROID): a US chart review study. Am Health Drug Benefits. 2012 Sep;5(6):347-58.

Lewis S, Price M, Mordin M, Dwyer K, Heekin R, Yates P, O'Brien S, Beverland D. Assessing performance following primary total knee arthroplasty: development of the patient's knee implant performance (PKIP) measure. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 7, 2012. [abstract] Value Health. 2012 Jun 1; 15(4):A70.

Chen S, Wu N, Boulanger L, Sacco P. Economic burden of refractory epilepsy with partial onset seizures: an assessment of direct health care resource use and costs. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A143.

Kitchen H, Rofail D, Heron L, Sacco P. Cognitive impairment associated with schizophrenia: a review of the humanistic burden. Adv Ther. 2012 Feb;29(2):148-62.

Hollis K, Calingaert B, Gilligan TM, Sweeney C, Price M, Perez-Gutthann S, Andrews E. Quinolones REMS evaluation surveys. Poster presented at the 27th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 18, 2011. Chicago, IL.

Heaney CD, Wing S, Campbell RL, Caldwell D, Hopkins B, Richardson D, Yeatts K. Relation between malodor, ambient hydrogen sulfide, and health in a community bordering a landfill. Environ Res. 2011 Aug;111(6):847-52. doi: 10.1016/j.envres.2011.05.021.

Wu N, Chen S, Boulanger L, Fraser K, Sacco P. Incidence, prevalence, and antiepileptic drug treatment patterns of patients with refractory partial onset seizures. Poster presented at the American Epilepsy Society; June 2011. Baltimore, MD.